Clinical Trial Update: Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update exploring ibrutinib in combination with radiation and temozolomide for newly diagnosed glioblastoma; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Ibrutinib (ibrutinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING